HEALTH CATALYST, INC. (HCAT): Price and Financial Metrics
HCAT Stock Summary
- HCAT's went public 1.61 years ago, making it older than only 1.93% of listed US stocks we're tracking.
- With a year-over-year growth in debt of 270.84%, Health Catalyst Inc's debt growth rate surpasses 94.73% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Health Catalyst Inc is reporting a growth rate of 85.09%; that's higher than 86.36% of US stocks.
- If you're looking for stocks that are quantitatively similar to Health Catalyst Inc, a group of peers worth examining would be RAMP, SVMK, VCRA, NEWR, and LPSN.
- HCAT's SEC filings can be seen here. And to visit Health Catalyst Inc's official web site, go to www.healthcatalyst.com.
HCAT Stock Price Chart Interactive Chart >
HCAT Price/Volume Stats
| Current price | $47.87 | 52-week high | $55.07 |
| Prev. close | $48.25 | 52-week low | $17.48 |
| Day low | $46.92 | Volume | 71,239 |
| Day high | $48.33 | Avg. volume | 461,525 |
| 50-day MA | $47.99 | Dividend yield | N/A |
| 200-day MA | $37.19 | Market Cap | 2.11B |
HEALTH CATALYST, INC. (HCAT) Company Bio
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.
Latest HCAT News From Around the Web
Below are the latest news stories about Health Catalyst Inc that investors may wish to consider to help them evaluate HCAT as an investment opportunity.
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call TranscriptHealth Catalyst, Inc. (HACT) Q4 2020 Earnings Conference Call February 25, 2021, 05:00 PM ET Company Participants Adam Brown - SVP, Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Robert Jones - Goldman Sachs Elizabeth Anderson - Evercore Stephanie Davis -... |
Recap: Health Catalyst Q4 EarningsShares of Health Catalyst (NASDAQ:HCAT) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 23.81% year over year to ($0.16), which beat the estimate of ($0.19). Revenue of $53,279,000 higher by 22.48% year over year, which beat the estimate of $52,120,000. Outlook Earnings guidance hasn't been issued by the company for now. Q1 revenue expected to be between $53,000,000 and $56,000,000. Conference Call Details Date: Feb 25, 2021 View more earnings on HCAT Time: 05:00 PM ET Webcast URL: https://edge.media-server.com/mmc/p/hqjrxviv Technicals Company's 52-week high was at $55.07 Company's 52-week low was at $17.48 Price action over last quarter: Up 31.34% Company Description Health Catalyst Inc is engaged in providing dat... |
Health Catalyst Reports Fourth Quarter and Year End 2020 ResultsSOUTH JORDAN, Utah, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2020. “In the fourth quarter of 2020, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly and full-year guidance for both revenue and Adjusted EBITDA,” said Dan Burton, CEO of Health Catalyst. “While 2020 represented an extremely challenging year across the healthcare ecosystem, I am proud of the part Health Catalyst played in supporting our customers to ensure they successfully managed through this unprecedented time. In particular,... |
Health Catalyst Inc to Host Earnings CallNEW YORK, NY / ACCESSWIRE / February 25, 2021 / Health Catalyst Inc (NASDAQ:HCAT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 5:00 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www. |
Transformation Capital Welcomes Jenna Ciotti and Akhi Samant to Its Growing Digital Health Investment TeamTransformation Capital, a leading digital health growth equity firm, today announces the addition of two investment professionals to the team: Jenna Ciotti as Vice President and Akhi Samant as Associate. |
HCAT Price Returns
| 1-mo | -3.25% |
| 3-mo | 30.29% |
| 6-mo | 48.99% |
| 1-year | 69.45% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 9.97% |
| 2020 | 25.45% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...